Digital Therapeutics: paving the way to better mental health treatment

Our GSP (Global Strategic Partners) programme provides a substantial cost-effective health-tech innovation platform that our partners build programs on top of. A GSP partner would gain a large-scale opportunity to enhance their brand, activate significant initiatives, product launches, and much more. The core responsibility is to build an entire module or show within the annual GIANT Health Event.

Some examples of the substantial benefits of this opportunity include:

  • Being the leader and taking the central role at GIANT Health 2020. I.e. inviting and engaging with the sponsors, exhibitors, and speakers within that program at GIANT.
  • Earning generous commission revenue from sponsorship and exhibition sales procured by the partner.
  • A powerful and impactful opportunity to engage internationally with leaders in the partner’s sector.
  • And consequently, substantial cost-effective brand, business networking, and sales and marketing benefits.

Reason behind conference track

 

Mental Health disorders is a global problem that can impact how a person feels, thinks, behaves, and interacts with society. Globally, an estimated 264 million people are affected by depression and as a whole more women are affected than men (World Health Organisation). Bipolar disorder affects roughly 45 million people worldwide, Schizophrenia affects 20 million people worldwide and approximately 50 million people have dementia globally (World Health Organisation)

According to the OECD, the cost of mental health problems in 2018 was about EUR 600 billion across the 28 EU countries (OECD). In the UK alone, the cost of mental ill health to the economy, the NHS and society as a whole is £105 billion a year (Department of Health, Gov.uk).

Inadequate response and treatment

 

  • "Health systems have not yet adequately responded to the burden of mental disorders. As a consequence, the gap between the need for treatment and its provision is wide all over the world. In low- and middle-income countries, between 76% and 85% of people with mental disorders receive no treatment for their disorder." (World Health Organisation)

  • Avivia's Health of the Nation Report surveyed 202 GPs in the UK in 2012 concluding with the finding that 75% had prescribed medication despite feeling psychological therapies would be more effective (Counselling Directory). 

  • “The financial drain on the workplace is staggering: mental illness accounts for $194 billion in lost revenue per year due to increased healthcare costs, lost productivity and absenteeism, according to the National Alliance on Mental Illness.” - Alyssa Place, 2020

     

 

Why digital therapeutics?

 

Basis: Digital therapeutics offer an alternative treatment to mental health problems that are tech-focused answers compared to traditional pharmacologic therapies.

Digital Therapeutics incorporates advanced data and analytics, engineering and personalised products that pharmaceutical companies can not. Technology advancement will continue to grow and pharmaceutical companies will need to adapt or partner with digital health companies to stay relevant (Mckinsey and Co).

“In January 2020, Octopus Ventures, one of the largest early stage investors in Europe and backers of mental-health-tech company Big Health, published results of new research showing that in 2019, VC investment in mental health technology reached £580 million” (Dr. James Somauroo, 2020).
The FDA, has adapted to digital health by facing  tech based products
through the creation of new regulation. One of the best examples of this is the FDA’s Digital Health Software Precertification Program, a pilot for approving software-based medical device (FDA, Digital Health).

 

 

 

 

Who we are looking for

 

This year Giant’s Virtual 2020 Event aims to showcase all the leading companies and individuals working to improve mental health treatment through the use of Digital Therapeutics and we need a partner to join us on this venture.  A Global Strategic Partner for this conference track can be a pioneering company working in this area or simply an incredibly ambitious individual or graduate seeking a rewarding experience in becoming the curator of this GIANT segment. We welcome all those who are interested. If this sounds like something you or your company could get involved in please check out the link here for an overview of the role of a GSP and the substantial benefits.

 

Who can undertake this role?

 

A Global Strategic Partner for this conference track can be a pioneering company working in this area or simply an incredibly ambitious individual or graduate seeking a rewarding experience in becoming the curator of this GIANT segment. We welcome all those are interested.

If you’re interested

 

If the GSP commitment interests you or your company, please reach out to our team members Zach or Isabella by email and they would be very happy to discuss this opportunity with you:

Zach Rubens

Isabella Pereira

Have a look below at some of the brilliant work being done in Digital Therapeutics